Analysis of urinary proteomic patterns for type 2 diabetic nephropathy by ProteinChip

Diabetes Research and Clinical Practice

Volumn 91, Issue 2, 2011, Pages 213-219

  Wu, Jing ^a   Chen, Yi Ding ^b   Yu, Jie Kai ^c   Shi, Xiao Li ^a   Gu, Wei ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Zhejiang University School of Medicine   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Biomarker; ProteinChip; SELDI TOF MS; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; HUMAN; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MOLECULAR WEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMOALBUMINURIA; PROTEIN MICROARRAY; PROTEIN URINE LEVEL; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TYPE 2 DIABETIC NEPHROPATHY; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; PROTEOMICS;

EID: 79952037563     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.11.036     Document Type: Article

References (28)

1. Boutayeb A., Boutayeb S. The burden of non communicable diseases in developing countries. Int J Equity Health 2005, 4(1):2.
2. Dihazi H., Müller G.A., Lindner S., Meyer M., Asif A.R., Oellerich M., et al. Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients. Clin Chem 2007, 53(9):1636-1645.
3. Yang Y.H., Zhang S., Cui J.F., Lu B., Dong X.H., Song X.Y., et al. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy. Diabet Med 2007, 24(12):1386-1392.
4. Rossing K. Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring. Dan Med Bull 2007, 54(2):79-98.
5. Wu J., Chen Y.D., Gu W. Urinary proteomics as a novel tool for biomarker discovery in kidney diseases. J Zhejiang Univ Sci B 2010, 11(4):227-237.
6. Mosley K., Tam F.W., Edwards R.J., Crozier J., Pusey C.D., Lightstone L. Urinary proteomic profiles distinguish between active and inactive lupus nephritis. Rheumatology (Oxford) 2006, 45(12):1497-1504.
7. Zhang X., Jin M., Wu H., Nadasdy T., Nadasdy G., Harris N., et al. Biomarker discovery for lupus nephritis through longitudinal urine proteomics. Kidney Int 2008, 74(6):799-807.
8. Ho J., Lucy M., Krokhin O., Hayglass K., Pascoe E., Darroch G., et al. Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case-control study. Am J Kidney Dis 2009, 53(4):584-595.
9. Nguyen M.T., Ross G.F., Dent C.L., Devarajan P. Early prediction of acute renal injury using urinary proteomics. Am J Nephrol 2005, 25(4):318-326.
10. Schaub S., Wilkins J.A., Antonovici M., Krokhin O., Weiler T., Rush D., et al. Proteomic-based identification of cleaved urinary β2-microglobulin as a potential marker of acute tubular injury in renal allograft. Am J Transplant 2005, 5(4 Pt 1):729-738.
11. Wang J.X., Yu J.K., Wang L., Liu Q.L., Zhang J., Zheng S. Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma. Proteomics 2006, 6(19):5344-5349.
12. Mao Y., Yu J., Chen J., Yang H., He Q., Shou Z., et al. Diagnosis of renal allograft subclinical rejection by urine protein fingerprint analysis. Transplant Immunol 2008, 18(3):255-259.
13. Wu J., Chen Y.D., Shi X.L., Gu W. Dipeptidyl peptidase IV (DPP IV): a novel emerging target for the treatment of type 2 diabetes. J Nanjing Med Univ 2009, 23(4):6-13.
14. Mogensen C.E., Christensen C.K., Vittinghus E. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes 1983, 32(Suppl. 2):64-78.
15. Overgaard A.J., Hansen H.G., Lajer M., Pedersen L., Tarnow L., Rossing P., et al. Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy. Proteome Sci 2010, 8:4.
16. Thongboonkerd V. Searching for novel biomarkers and new therapeutic targets of diabetic nephropathy using proteomics approaches. Contrib Nephrol 2008, 160:37-52.
17. Gu W., Zou L.X., Shan P.F., Chen Y.D. Analysis of urinary proteomic patterns for diabetic nephropathy by ProteinChip. Proteomics Clin Appl 2008, 2:744-750.
18. Jain S., Rajput A., Kumar Y., Uppuluri N., Arvind A.S., Tatu U. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder. J Assoc Phys India 2005, 53:513-520.
19. Schiffer E., Mischak H., Zimmerli L.U. Proteomics in gerontology: current applications and future aspects-a mini-review. Gerontology 2009, 55(2):123-137.
20. Huang F., Clifton J., Yang X., Rosenquist T., Hixson D., Kovac S., et al. SELDI-TOF as a method for biomarker discovery in the urine of aristolochicacid-treated mice. Electrophoresis 2009, 30(7):1168-1174.
21. Out H.H., Can H., Spentzos D., Nelson R.G., Hanson R.L., Looker H.C., et al. Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy. Diabetes Care 2007, 30(3):638-643.
22. Carpena M.P., Rados D.V., Sortica D.A., Souza B.M., Reis A.F., Canani L.H., et al. Genetics of diabetic nephropathy. Arq Bras Endocrinol Metabol 2010, 54(3):253-261.
23. Freedman B.I., Bowden D.W., Sale M.M., Langefeld C.D., Rich S.S. Genetic susceptibility contributes to renal and cardiovascular complications of type 2 diabetes mellitus. Hypertension 2006, 48(1):8-13.
24. Somorjai R.L., Dolenko B., Baumgartner R. Class prediction and discovery using gene microarray and proteomics mass spectroscopy data: curses, caveats, cautions. Bioinformatics 2003, 19(12):1484-1491.
25. Vapnik V. The nature of statistical learning theory 1995, Springer Verlag, New York.
26. Jorissen R.N., Gilson M.K. Virtual screening of molecular databases using a support vector machine. J Chem Inf Model 2005, 45(3):549-561.
27. Liu D., Cao L., Yu J., Que R., Jiang W., Zhou Y., et al. Diagnosis of pancreatic adenocarcinoma using protein chip technology. Pancreatology 2009, 9(1-2):127-135.
28. Sun G., He H., Ping F., Zhang F. Proteomic diagnosis models from serum for early detection of oral squamous cell carcinoma. Artif Cells Blood Substit Immobil Biotechnol 2009, 37(3):125-129.